Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae-Cheol Lee

Showing results (111-120 of 226) with videos related to

Pageof 23
Sort By:
Plos One|December 17, 2013
Role of IGF-binding protein 3 in the resistance of EGFR mutant lung cancer cells to EGFR-tyrosine kinase inhibitorsYun Jung Choi, Gun Min Park, Jin Kyung Rho, et al.
Cancer Chemotherapy and Pharmacology|November 26, 2014
EGFR-TKI is effective regardless of treatment timing in pulmonary adenocarcinoma with EGFR mutationDong-Hoe Koo, Kyu-pyo Kim, Chang-Min Choi, et al.
Molecular Cancer|January 29, 2018
Extracellular vesicle-derived DNA for performing EGFR genotyping of NSCLC patientsJae Young Hur, Hee Joung Kim, Jong Sik Lee, et al.
The EMBO Journal|October 23, 2012
Wig1 prevents cellular senescence by regulating p21 mRNA decay through control of RISC recruitmentBong Cho Kim, Hyung Chul Lee, Je-Jung Lee, et al.
BMC Cancer|June 27, 2021
Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lungYoon Jung Jang, Dong-Gon Hyun, Chang-Min Choi, et al.
Cells|December 8, 2020
Efficacy of the CDK7 Inhibitor on EMT-Associated Resistance to 3rd Generation EGFR-TKIs in Non-Small Cell Lung Cancer Cell LinesWonjun Ji, Yun Jung Choi, Myoung-Hee Kang, et al.
Proteomics|June 20, 2014
Extracellular vesicles shed from gefitinib-resistant nonsmall cell lung cancer regulate the tumor microenvironmentDo-Young Choi, Sungyong You, Jae Hun Jung, et al.
Radiology|July 18, 2018
Non-Small Cell Lung Cancer with Resistance to EGFR-TKI Therapy: CT Characteristics of T790M Mutation-positive CancerHyun Jung Koo, Mi Young Kim, Sojung Park, et al.
Clinical Lung Cancer|February 16, 2015
Survival Benefit of Pemetrexed in Lung Adenocarcinoma Patients With Anaplastic Lymphoma Kinase Gene RearrangementsSojung Park, Tai Sun Park, Chang-Min Choi, et al.
Thoracic Cancer|July 29, 2022
Sex differences in the characteristics and survival of patients with non-small-cell lung cancer: A retrospective analytical study based on real-world clinical data of the Korean populationDa Som Jeon, Jin Woo Kim, Seul Gi Kim, et al.
Pageof 23

Showing results (111-120 of 226) with videos related to

Sort By:
Pageof 23
Plos One|December 17, 2013
Role of IGF-binding protein 3 in the resistance of EGFR mutant lung cancer cells to EGFR-tyrosine kinase inhibitorsYun Jung Choi, Gun Min Park, Jin Kyung Rho, et al.
Cancer Chemotherapy and Pharmacology|November 26, 2014
EGFR-TKI is effective regardless of treatment timing in pulmonary adenocarcinoma with EGFR mutationDong-Hoe Koo, Kyu-pyo Kim, Chang-Min Choi, et al.
Molecular Cancer|January 29, 2018
Extracellular vesicle-derived DNA for performing EGFR genotyping of NSCLC patientsJae Young Hur, Hee Joung Kim, Jong Sik Lee, et al.
The EMBO Journal|October 23, 2012
Wig1 prevents cellular senescence by regulating p21 mRNA decay through control of RISC recruitmentBong Cho Kim, Hyung Chul Lee, Je-Jung Lee, et al.
BMC Cancer|June 27, 2021
Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lungYoon Jung Jang, Dong-Gon Hyun, Chang-Min Choi, et al.
Cells|December 8, 2020
Efficacy of the CDK7 Inhibitor on EMT-Associated Resistance to 3rd Generation EGFR-TKIs in Non-Small Cell Lung Cancer Cell LinesWonjun Ji, Yun Jung Choi, Myoung-Hee Kang, et al.
Proteomics|June 20, 2014
Extracellular vesicles shed from gefitinib-resistant nonsmall cell lung cancer regulate the tumor microenvironmentDo-Young Choi, Sungyong You, Jae Hun Jung, et al.
Radiology|July 18, 2018
Non-Small Cell Lung Cancer with Resistance to EGFR-TKI Therapy: CT Characteristics of T790M Mutation-positive CancerHyun Jung Koo, Mi Young Kim, Sojung Park, et al.
Clinical Lung Cancer|February 16, 2015
Survival Benefit of Pemetrexed in Lung Adenocarcinoma Patients With Anaplastic Lymphoma Kinase Gene RearrangementsSojung Park, Tai Sun Park, Chang-Min Choi, et al.
Thoracic Cancer|July 29, 2022
Sex differences in the characteristics and survival of patients with non-small-cell lung cancer: A retrospective analytical study based on real-world clinical data of the Korean populationDa Som Jeon, Jin Woo Kim, Seul Gi Kim, et al.
Pageof 23